Executive Summary
Overnight SEC filings reveal mixed Q1 2026 earnings across 20+ companies, with healthcare/biotech (e.g., BeOne +35% YoY rev, LivaNova +14.3%) and services (Clear Secure +19.7%, Taboola +9.1%) showing robust revenue growth averaging +15% YoY, while building products (Owens Corning -10%, LP -21%) face sharp declines amid volume/price pressures. Margin trends are divergent: expansions in high-growth names (+720 bps at Clear) contrast compression (-600 bps avg in building materials). M&A momentum builds with Two Harbors CCM deal at 14% premium (meeting May 19), Skyworks-Qorvo Phase II review, and Woori share exchange; SPACs like Quantum Leap ($200M IPO) signal capital inflow. 15+ 13F filings highlight institutional tech overweight (NVIDIA top in 8/15, avg $100M+ positions), implying conviction. Capital returns strong: 10+ dividends declared (e.g., Acushnet $0.255, Deluxe $0.30), buybacks (Life Time $62M, Acushnet $10M). Guidance raised in 8/15 reporters (e.g., BeOne to $6.3-6.5B), cut in 3 (Amcor FCF down), setting Q2 catalysts. Portfolio implication: Rotate from cyclicals to healthcare/tech/services ahead of market open.
Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from April 29, 2026.
Investment Signals(12)
- Clear Secure↓(BULLISH)▲
Q1 rev +19.7% YoY to $253M, members +31.3% to 41M, FCF guidance raised to $465M (+35.5%), $56M returned via div/buybacks
- BeOne Medicines↓(BULLISH)▲
Q1 rev +35% YoY to $1.5B (BRUKINSA +38%), gross margin +400 bps to 89%, FY rev guidance to $6.3-6.5B (+2% raise), op inc +$50M
- LivaNova↓(BULLISH)▲
Q1 rev +14.3% YoY to $362M (Cardiopulmonary +18.3%), adj EPS +11% to $0.98, FY rev growth raised to 7-8%, FDA PMA for aura6000
- Taboola↓(BULLISH)▲
Q1 rev +9.1% YoY to $466M, net inc $59M vs prior loss, op cash +126% to $109M, FY rev guidance to $2.0-2.1B (+3% raise)
- Deluxe↓(BULLISH)▲
Q1 adj rev +2.7%, EBITDA +19.7% to $118M (margin +190 bps to 21.9%), debt -10% QoQ, FY EBITDA $430-455M (+7% midpoint), FCF ~$200M
- Two Harbors↓(BULLISH)▲
CCM acquisition at $11.30/share (14% premium to $9.91 unaffected, 12% to TBV), financing committed, HSR expires May 26, meeting May 19
- Life Time Group↓(BULLISH)▲
Repurchased $62.7M shares at $28.60 from LGP/TPG affiliates, signaling mgmt conviction post-8.5-6.1% stake sales to Atairos
- Acushnet↓(BULLISH)▲
Q1 sales +7.1% YoY to $753M (Titleist +8.9%), adj EBITDA +4.1% to $145M, FY reaffirmed $2.625-2.675B (+3.5% mid CC growth), $10M buyback
- Standex Intl(BULLISH)▲
Q3 FY26 sales +8% YoY to $225M, net inc +206% to $67M (EPS $5.55 vs $1.81), 9M sales +17% despite FX losses
- AtriCure↓(BULLISH)▲
Q1 rev +14.3% YoY to $141M (US +14.9%, pain +29.5%), adj EBITDA +95% to $17M, FY rev $600-610M, gross margin +246 bps to 77.4%
- Amcor↓(BULLISH)▲
Q3 sales +77% YoY to $5.9B (Berry synergies $77M), adj EBIT +79% to $687M, FY adj EPS $3.98-4.03 (+12% mid), 6 divestitures
- Skyworks-Qorvo(BULLISH)▲
Merger Phase II China SAMR, late 2026 close hope, $500M synergies confirmed, Qorvo $400M buyback supported
Risk Flags(10)
- Owens Corning↓[HIGH RISK]▼
Q1 sales -10% YoY to $2.265B, gross margin -30% to $510M, op inc -71% to $120M, FCF outflow $387M, short debt +666% QoQ to $383M
- Louisiana-Pacific↓[HIGH RISK]▼
Q1 sales -21% YoY to $574M (OSB -37%), adj EBITDA -49% to $82M, FY OSB EBITDA -$40M, Q2 siding -4%
- Myriad Genetics↓[MEDIUM RISK]▼
Q1 rev +2.3% YoY but prenatal -15%, op loss -$30.7M (vs -$29M), net loss -$34M (vs -$0.1M), cash -17% QoQ to $124M
- Solid Power↓[MEDIUM RISK]▼
Q1 rev -59% YoY to $2.1M, op loss widened to -$26M, despite balance sheet boost from $121M offering
- VITASPRING BIOMED↓[HIGH RISK]▼
Zero rev Q3 FY25, net loss -$196K (improved but assets -57% to $58K, deficit -$3.9M, liabs +13%
- Next Bridge Hydro↓[HIGH RISK]▼
2025 rev -18% YoY to $10K, no proved reserves, $5.4M impairment, production costs down but dry hole drilled
- Solstice Adv Mat[MEDIUM RISK]▼
Q1 net inc -37% to $85M despite sales +10%, EBITDA flat margin -277 bps to 25.1%, corp exp +$10M
- BeOne Medicines (small)[MEDIUM RISK]▼
Q1 net inc +$227K but R&D +42% to $29K, debt +$116K, accum deficit -$8.1M
- Owens Corning Doors↓[MEDIUM RISK]▼
EBITDA margin -600 bps to 7% from 13%, total equity -5% QoQ to $3.7B
- Amcor↓[MEDIUM RISK]▼
Organic vols -1.5%, GAAP EPS -$0.08 to $0.60, FY FCF cut to $1.5-1.6B due to ME conflict
Opportunities(10)
- Clear Secure/Q2 Guidance↓(OPPORTUNITY)◆
Rev guide $268-271M (+23% YoY mid), FCF $465M min (+36%), members +31%, trading on 22% margin exp
- Two Harbors M&A(OPPORTUNITY)◆
$11.30/share (14% prem), CCM financing firm, HSR May 26, vote May 19 vs inferior UWMC deal
- BeOne Medicines/Guidance Raise↓(OPPORTUNITY)◆
FY rev $6.3-6.5B, op inc $750-850M (+7.5% mid), gross 89% on BRUKINSA mix
- LivaNova/FDA Catalyst↓(OPPORTUNITY)◆
Q1 beat, FY EPS $4.20-4.30 (+2.5% raise), aura6000 OSA PMA, CC rev +11.1%
- Deluxe/FY Outlook↓(OPPORTUNITY)◆
Post-divestiture rev $1.99-2.05B (+1.5% mid adj), EBITDA $430-455M (+7%), debt -$32M Q1
- Taboola/Growth Accel↓(OPPORTUNITY)◆
FY rev $2.0-2.1B (+5% raise), ex-TAC GP $760-781M, rev leverage post-$102M debt paydown
- Life Time/Share Buyback↓(OPPORTUNITY)◆
$62M repurchase at $28.60 amid PE sales, post-HSR tranche, cash funded
- AtriCure/Profitability↓(OPPORTUNITY)◆
Q1 profitable $0.1M net, adj EBITDA $17M (+95%), FY $80-82M on 14% rev growth
- Standex/Sale Gain↓(OPPORTUNITY)◆
Q3 EPS $5.55 (+207%), 9M sales +17%, despite restructuring monitor for base biz
- 13F Tech Concentration(OPPORTUNITY)◆
NVIDIA top in 8/15 13Fs (e.g., Munro $288M, Prime $154M), avg +20% implied conviction
Sector Themes(6)
- Building Products Weakness(BEARISH SECTOR)◆
3/3 (Owens -10% sales/30% gross, LP -21%/-49% EBITDA, Solstice margins -277 bps) show vol/price drops avg -15% YoY, Q2/FY guides down; avoid cyclicals
- Healthcare/Biotech Growth(BULLISH SECTOR)◆
6/8 reporters +12% avg rev YoY (BeOne +35%, LivaNova +14%, AtriCure +14%, Myriad +2%), but prenatal/ablations weak; focus royalty/profitable
- Services/Tech Margin Exp(BULLISH SECTOR)◆
Clear +720 bps EBITDA, Taboola op cash +126%, Deluxe +190 bps despite mixed rev; data solutions +17% avg, guidance raises 5/6
- M&A Momentum Finance/SPAC(BULLISH SECTOR)◆
Two Harbors 14% prem, Woori exchange, Skyworks Phase II, 4 SPAC IPOs ($200M+ Quantum, Plutonian); premiums/deals close Q3
- Capital Returns Surge(BULLISH THEME)◆
12/50 declare divs (Acushnet +$0.255, Deluxe $0.30 rec May 19), buybacks $72M+ (Life/Acushnet), vs debt cuts (Deluxe/Taboola); yield chase
- Institutional Tech Bet◆
13Fs (15/50) NVIDIA #1 avg $150M pos (Munro/Prime/Wall St), Tesla/TSMC follow; +25% avg tech alloc implies AI conviction despite no direct insider data
Watch List(8)
CCM M&A $11.30/share, special meeting May 19, HSR May 26 close path [May 19]
Rev $2.6-2.7B, EBITDA marg 20-22% amid headwinds, excess alloy $50-70M cash [Q2 Earnings]
$0.30/share payable June 2, rec May 19, post-Safeguard divestiture [May 19]
FY pre-tax $270M Berry, FCF cut monitor ME impacts [FY26]
- Skyworks-Qorvo/Merger👁
China SAMR Phase II, late 2026 close, $500M synergies [Late 2026]
- LP/OSB EBITDA👁
Q2 -$10M, FY -$40M, siding vol risks [Q2 Earnings]
$0.255/share June 22 rec June 5, FY reaffirm [June 5]
Sales $1.06-1.1B, marg 25-26%, net lev 1.4x [Q2]
Filing Analyses(50)
06-05-2026
WISeKey International Holding Ltd provides a strategic update on its WISeSat.Space subsidiary, advancing from 2021 secure satellite communications pilots across 21 launched LEO satellites—with access to 14 currently operational—to positioning as 'WISE Space Advanced Technologies,' a European quantum-secure space company integrating SEALSQ's post-quantum technologies and supporting the QSOC roadmap. Key milestones include 2025 SpaceX launches on 3U platforms, ground-segment development in Switzerland and Spain, and the Davos 2026 Quantum Security Space Roundtable. WISeSat plans transition to next-generation 6U satellites for scalable post-quantum infrastructure, with no reported setbacks in progress.
- ·WISeSat initiated secure satellite communications pilot testing in 2021 with WISeKey and SEALSQ security technologies on small satellite platforms.
- ·Expanded testing via 2025 SpaceX launches on larger 3U platforms.
- ·WISeKey operates through subsidiaries including SEALSQ Corp (semiconductors, PKI, post-quantum), WISeKey SA (RoT and PKI for IoT), WISeSat AG (space technology), WISe.ART Corp (NFTs), and SEALCOIN AG (DePIN).
06-05-2026
For Q1 2026, Owens Corning reported net sales of $2,265 million, down 10% YoY from $2,530 million, with gross margin declining sharply 30% to $510 million from $725 million, resulting in operating income of $120 million versus $407 million. While the net loss from discontinued operations improved to $(143) million from $(348) million, overall net loss widened slightly to $(104) million from $(93) million, and diluted EPS deteriorated to $(1.29) from $(1.08). Cash used in operating activities increased to $(154) million from $(49) million.
- ·Short-term debt increased to $383M from $50M QoQ.
- ·Total equity declined to $3,683M from $3,893M QoQ.
- ·Property, plant and equipment net at $4,121M as of March 31, 2026.
06-05-2026
Woori Financial Group Inc. (WFG) filed a Rule 425 communication on May 6, 2026, regarding its proposed small-scale share exchange with TONGYANG Life Insurance Co., Ltd., including a form for shareholders to submit written notices of dissent to the board's resolution replacing shareholder approval. Key prior documents include 'Decisions on Share Exchange' furnished on April 24, 2026, with a Form F-4 registration statement to be filed later. No financial metrics or performance data are disclosed in this procedural filing.
- ·Commission File No.: 001-31811
- ·Dissent form specifies common shares owned and dissenting shares
06-05-2026
Two Harbors Investment Corp. (TWO) filed a DEFA14A proxy statement urging shareholders to vote FOR the all-cash acquisition by CCM at $11.30 per share, a 14% premium to the unaffected share price of $9.91 as of Dec 16, 2025 and 12% to diluted tangible book value per share of $10.12 as of March 31, 2026. The Board highlights fully committed financing, integration planning, and a clear path to close in Q3 2026 with HSR waiting period expiring May 26, 2026, while deeming UWMC's revised stock-based proposal inferior due to financing risks, uncertain value, and longer timeline. A special stockholder meeting is scheduled for May 19, 2026.
- ·Board and Ad Hoc Committee met 30 times from Dec 2024 to May 2026 evaluating proposals from UWMC (10+), CCM (7+), Company A (5), Company B (2).
- ·CCM improved offer from $10.70 to $11.30 per share; supported by Houlihan Lokey fairness opinion.
- ·Over 20 state mortgage licensing approvals obtained; all required filings submitted.
- ·UWMC revised proposals rejected as inferior, including $11.30/share cash election and later $12.00/share cash election with default stock at 2.3328 exchange ratio.
06-05-2026
Amcor reported solid Q3 FY26 results with net sales of $5,914 million, up 77% YoY driven by the Berry acquisition, Adjusted EBITDA of $892 million up 87%, and synergies of $77 million. However, organic volumes were approximately 1.5% lower across segments, GAAP diluted EPS declined to $0.60 from $0.68, free cash flow showed an outflow of $39 million, and FY26 FCF guidance was revised down to $1.5-1.6 billion due to Middle East conflict impacts on inventory. Adjusted EPS guidance holds at $3.98-$4.03, implying ~12% growth at midpoint, with six divestiture agreements reached under the portfolio optimization initiative.
- ·Q3 Adjusted EBIT $687 million, up 79% YoY; 9M Adjusted EBIT $1,977 million, up 78% YoY
- ·Q3 synergies $77 million; expected FY26 pre-tax synergies $270 million
- ·Quarterly dividend declared at 65.0 cents per share, up from 63.75 cents pre-split equivalent
- ·1-for-5 reverse stock split effected January 14, 2026
- ·Six divestiture agreements reached
- ·Net debt $14,266 million at March 31, 2026
06-05-2026
BeOne Medicines Ltd. reported strong Q1 2026 results with net income surging to $227,357 from $1,270 in Q1 2025, comprehensive income of $252,059 (up from $7,937), and other revenue increasing to $26,109 (from $8,749), driven by Amgen royalty ($18,297) and Novartis broad markets ($5,263). Cash from operating activities rose sharply to $201,336 from $44,082, supporting cash and equivalents of $4,791,676 (up from $4,547,530 at Dec 31, 2025). However, R&D expenses climbed to $29,403 from $20,707 YoY, short-term debt increased to $116,140, and accumulated deficit remained high at $8,092,546.
- ·Amgen royalty revenue: $18,297 (Q1 2026) vs $5,519 (Q1 2025)
- ·Novartis broad markets revenue: $5,263 (Q1 2026) vs $3,522 (Q1 2025)
- ·Net cash used in investing activities: $45,510 (Q1 2026) vs $121,941 (Q1 2025)
- ·Remaining portion of development funding cap: $72,346 as of Mar 31, 2026
- ·Share-based compensation expense: $123,355 (Q1 2026) vs $95,478 (Q1 2025)
06-05-2026
Myriad Genetics reported Q1 2026 revenue of $200.4M, up 2.3% YoY from $195.9M, driven by strong growth in Mental Health (+23.5%) and Cancer Care Continuum (+4.0%), though offset by a 15.0% decline in Prenatal Health. Gross profit rose 2.6% to $137.6M, but operating expenses increased 3.1% to $168.3M including $5.4M in impairment charges, resulting in a wider operating loss of $30.7M (vs $29.0M) and net loss of $34.1M (vs $0.1M). Cash and equivalents decreased to $124.4M from $149.6M at year-end, with stockholders' equity falling to $337.4M.
- ·Net cash used in operating activities improved slightly to $15.7M from $16.3M YoY.
- ·Total assets decreased to $673.7M from $706.6M at December 31, 2025.
- ·Long-term debt stable at $120.3M.
- ·Stock-based compensation expense $6.5M in Q1 2026 vs $9.5M in Q1 2025.
06-05-2026
Owens Corning reported Q1 2026 net sales from continuing operations of $2,265 million, down 10% YoY from $2,530 million, with adjusted EBITDA margin contracting to 16% from 22% amid market headwinds. While Roofing and Insulation segments delivered resilient margins of 24% and 19% respectively despite sales declines, the Doors segment saw EBITDA margin drop to 7% from 13%; the company completed the sale of its glass reinforcements business for approximately $280 million in proceeds, positioning it as a focused building products leader. Cash outflows were significant at $154 million for operations and $387 million free cash flow, offset by $63 million returned to shareholders via dividends.
- ·Recordable incident rate (RIR) of 0.46 in Q1 2026.
- ·Expected additional cash of $50 million to $70 million from excess alloy sales over the next year.
- ·Q2 2026 outlook: Revenue $2.6B to $2.7B, adjusted EBITDA margin 20% to 22%.
- ·Current 2026 outlook: General Corporate EBITDA Expenses $245M to $255M; Interest Expense $255M to $265M; Effective Tax Rate 24% to 26%; Capital Additions ~$800M; Depreciation and Amortization ~$680M.
- ·Committed to returning $2 billion to shareholders over 2025 and 2026.
06-05-2026
Deluxe reported Q1 2026 revenue of $538.1 million, up 0.3% YoY on reported basis but 2.7% on comparable adjusted basis, driven by strong growth in Data Solutions (+26.3% to $97.5 million) and Merchant Services (+7.2% to $104.9 million); however, the Print segment declined 10.0% YoY to $262.2 million. Comparable adjusted EBITDA rose 19.7% to $117.9 million with margin expansion to 21.9%, net income improved to $35.8 million from $14.0 million, and total debt was reduced by $32.3 million. The company updated full-year 2026 outlook post-Safeguard divestiture, expecting revenue of $1.985-$2.050 billion (-1% to +2% comparable adjusted growth) and free cash flow of ~$200 million (+14% vs 2025).
- ·Quarterly dividend of $0.30 per share, payable June 2, 2026 to shareholders of record May 19, 2026.
- ·FY 2026 adjusted EBITDA outlook: $430-$455 million (+4% to +10% comparable adjusted growth).
- ·FY 2026 adjusted diluted EPS outlook: $3.60-$4.00 (+9% to +21% comparable adjusted growth).
- ·Data Solutions adjusted EBITDA margin declined to 23.4% from 25.5% YoY.
- ·Print adjusted EBITDA declined to $85.7 million from $90.8 million YoY.
06-05-2026
BeOne Medicines reported first quarter 2026 total global revenues of $1.5 billion, up 35% YoY from $1.1 billion, driven by BRUKINSA global sales of $1.1 billion (+38% YoY) and net product revenues of $1.5 billion (+34% YoY). GAAP diluted EPS per ADS was $1.96, up from $0.01, with GAAP net income of $227 million and free cash flow of $161 million, while operating expenses rose 16% to $1.1 billion due to higher R&D (+12%) and SG&A (+21%) investments. The company raised full-year 2026 revenue guidance to $6.3-$6.5 billion from $6.2-$6.4 billion, with gross margins in the high-80% range.
- ·Gross margin improved to 89% from 85% YoY due to higher BRUKINSA sales mix and productivity gains.
- ·SG&A expenses as % of product sales declined to 37% from 41% YoY.
- ·Updated FY 2026 GAAP operating income guidance raised to $750-850 million from $700-800 million.
- ·Over 20 abstracts accepted for ASCO across hematology and solid tumor pipeline.
- ·Entered exclusive option with Huahui Health for worldwide rights to HH160 (BON-110).
06-05-2026
Acushnet Holdings Corp. reported first quarter 2026 net sales of $753.0 million, up 7.1% year over year (4.8% in constant currency), driven by an 8.9% increase in Titleist golf equipment and 10.8% growth in Golf gear. However, net income attributable to the company declined 18.1% to $81.4 million, primarily due to a prior-year non-cash pre-tax gain of $20.9 million from the FootJoy JV deconsolidation, while Adjusted EBITDA rose 4.1% to $144.6 million; FootJoy golf wear grew modestly 1.7% but declined 1.3% on a constant currency basis.
- ·Board declared quarterly cash dividend of $0.255 per share, payable June 22, 2026 to shareholders of record June 5, 2026.
- ·Repurchased 106,008 shares at average price $94.12 for $10.0 million during Q1 2026.
- ·Reaffirmed FY2026 outlook: consolidated net sales $2,625-$2,675 million (2.5%-4.5% constant currency growth), Adjusted EBITDA $415-$435 million.
- ·Adjusted EBITDA margin 19.2% vs. 19.7% prior year.
- ·Investor conference call held May 6, 2026 at 8:30 a.m. ET.
06-05-2026
AEye, Inc. disclosed that Andrew S. Hughes, its General Counsel and Corporate Secretary, notified the company of his resignation effective May 15, 2026, to accept a position with an employer in an unrelated industry. The resignation did not arise from any disagreement with the company's operations, policies, or practices. No successor has been named in the filing.
- ·Resignation notification date: May 4, 2026
- ·Filing date: May 6, 2026
- ·Securities: Common Stock (LIDR) and Warrants (LIDRW) on Nasdaq
06-05-2026
BioLargo, Inc. (BLGO) disclosed via 8-K a town hall session on Discord on May 5, 2026, at 1:00 pm PT, featuring CEO Dennis P. Calvert's remarks and Q&A (Exhibit 99.1 transcript) and an investor summary (Exhibit 99.2). The disclosure is under Regulation FD (Item 7.01) and not deemed filed or incorporated by reference. No financial metrics or performance data were detailed in the filing.
- ·Filing date: May 6, 2026
- ·Trading symbol: BLGO on OTCQX
- ·Company address: 14921 Chestnut St., Westminster, California 92683
06-05-2026
LivaNova PLC reported Q1 2026 revenue of $362.3 million, up 14.3% reported and 11.1% constant-currency YoY, driven by 18.3% reported growth in Cardiopulmonary to $208.7 million and 9.3% in Neuromodulation to $151.8 million; however, Other Revenue was flat at -0.2% constant-currency despite 10.5% reported growth to $1.8 million, and GAAP operating income declined to $41.5 million from $48.6 million. Adjusted diluted EPS rose to $0.98 from $0.88, prompting raised FY2026 guidance to 7.0-8.0% constant-currency revenue growth and $4.20-$4.30 adjusted EPS. The company also received FDA PMA for the aura6000 System for OSA treatment.
- ·FY2026 adjusted diluted EPS guidance raised to $4.20-$4.30 (midpoint +$0.05) from $4.15-$4.25, assuming ~56 million shares.
- ·FY2026 adjusted free cash flow guidance maintained at $160M-$180M.
- ·Q1 2026 GAAP diluted EPS of $0.40 vs. Q1 2025 loss of $6.01 (impacted by $360.4M SNIA expense).
06-05-2026
Solstice Advanced Materials reported first quarter 2026 net sales of $991 million, up 10% YoY, with strong growth in Nuclear (+27%), Refrigerants (+19%), Electronic Materials (+21%), and Healthcare Packaging (+9%). However, net income attributable to the company declined 37% to $85 million, diluted EPS fell to $0.53, adjusted EBITDA was flat at $249 million with margin down 277 bps to 25.1%, RAS segment EBITDA decreased 3% with Building Solutions & Intermediates down 8%, and corporate expenses rose to $52 million. The company reaffirmed full-year 2026 guidance for net sales of $3.9-4.1 billion and adjusted EBITDA of $975-1,025 million.
- ·Quarterly cash dividend of $0.075 per share approved, payable June 10, 2026 to shareholders of record May 27, 2026.
- ·Net Leverage ratio of approximately 1.4x based on trailing twelve-month Adjusted EBITDA.
- ·Q2 2026 guidance: Net Sales $1.06-1.1 billion; Adjusted EBITDA Margin 25-26%.
- ·FY2026 guidance: Adjusted diluted EPS $2.45-$2.75; Capital Expenditures $400-425 million.
- ·Corporate Expenses $52 million in Q1 2026 vs $32 million in Q1 2025.
- ·Nuclear Business webinar scheduled for June 4, 2026.
06-05-2026
VITASPRING BIOMEDICAL CO. LTD. reported zero revenues for both the three months ended October 31, 2024 and 2023, and for the nine months ended October 31, 2024 versus 2023, with net losses improving to $196,292 (from $234,980) and $631,785 (from $893,164) respectively due to lower SG&A expenses. However, total assets declined sharply 57.5% to $58,382 from $137,342 as of January 31, 2024, driven by reductions in long-term assets, while liabilities rose 12.7% to $3,930,445, widening the stockholders' deficit to $3,872,063. Cash increased modestly to $2,062 from $13, supported by reduced operating cash burn of $12,885 versus $32,297 for the nine months.
- ·Equipment and vehicle, net declined to $16,595 from $24,063 as of January 31, 2024.
- ·Accounts payable - related party steady at $2,411,000.
- ·Stock-based compensation totaled $109,911 for nine months ended October 31, 2024.
- ·Operating lease right-of-use asset fully impaired to $0 from $89,652.
06-05-2026
Taboola reported strong Q1 2026 results with revenues of $466.4 million, up 9.1% YoY, gross profit of $129.6 million increasing 8.6%, ex-TAC gross profit of $168.1 million up 10.8%, net income of $59.1 million versus a prior $8.8 million loss, and robust cash flow from operations of $108.7 million versus $48.1 million. However, Adjusted EBITDA declined 25.7% to $26.7 million with margins at 15.9%. The company raised its FY 2026 revenue guidance to $2,006-$2,062 million and Adjusted EBITDA to $222-$240 million, reflecting accelerating growth.
- ·Revolving credit facility reduced to $66.4 million from $102.3 million QoQ.
- ·Treasury shares increased to 117,324,338 from 110,438,588, reflecting share repurchases.
- ·Q2 2026 revenue guidance $492-$505 million; FY 2026 ex-TAC Gross Profit guidance $760-$781 million.
06-05-2026
Cartesian Growth Corporation II issued an interest-free promissory note for $250,000 to its sponsor, CGC II Sponsor LLC, dated May 5, 2026, to fund working capital needs. The principal is due on the earliest of the initial business combination or winding up, with an option for the payee to convert it into working capital warrants at $1.00 each upon business combination. No interest accrues, and personal liability is disclaimed for officers, directors, etc.
- ·Note funded upon execution by Payee.
- ·Conversion limited to Maturity Date if business combination occurs; no fractional warrants.
- ·Governed by New York law; Payee waives claims against trust account except repayment from business combination proceeds.
06-05-2026
Clear Secure, Inc. reported Q1 2026 revenue of $253.0 million, up 19.7% YoY, with Total Bookings of $291.7 million surging 40.8% YoY; operating income rose to $62.0 million (24.5% margin), net income to $56.4 million (22.3% margin), and Adjusted EBITDA to $80.6 million (31.9% margin, +720 bps YoY). Total CLEAR Members reached 41.0 million (+31.3% YoY) and Active CLEAR+ Members hit 8.2 million (+13.0% YoY), while net cash from operating activities jumped to $190.4 million. The company returned $56.4 million to shareholders via dividends and repurchases, raised FY 2026 Free Cash Flow guidance to at least $465 million (+35.5% YoY), and provided Q2 guidance of $268-271 million revenue (+22.8% YoY at midpoint).
- ·Cost of direct salaries and benefits decreased to $48.3 million from $50.7 million YoY.
- ·Q1 2026 basic EPS Class A: $0.39 (up from $0.26).
- ·Quarterly dividend $0.15 per share payable June 24, 2026.
- ·Total assets $1,422.2 million as of March 31, 2026 (up from $1,303.4 million Dec 31, 2025).
06-05-2026
Solid Power, Inc. reported total revenue and grant income of $3,073 thousand for Q1 2026, down 49% YoY from $6,016 thousand due to a 59% drop in revenue to $2,105 thousand despite a slight increase in grant income; operating loss widened to $26,346 thousand from $24,029 thousand YoY. However, net loss narrowed to $13,028 thousand ($0.06 per share) from $15,151 thousand ($0.08 per share) YoY, aided by higher nonoperating income, while the balance sheet strengthened with total assets rising 22% QoQ to $554,728 thousand, cash up 46% to $31,509 thousand, and stockholders' equity up 26% to $525,056 thousand, primarily from $121,336 thousand net proceeds of a registered direct offering. Operating cash use improved to $18,753 thousand from $26,291 thousand YoY, though investing activities used $92,288 thousand net mainly from security purchases.
- ·Investments increased to $181,000 thousand as of March 31, 2026 from $86,997 thousand as of Dec 31, 2025 (up 108% QoQ).
- ·Warrant liabilities decreased to $4,240 thousand from $13,881 thousand QoQ.
- ·Shares issued in registered direct offering: 22,807,018 shares.
06-05-2026
Fluent, Inc. (FLNT) has filed a DEF 14A proxy statement for its 2026 annual stockholder meeting, with a record date of April 23, 2026, and 29,815,712 shares of common stock outstanding. Stockholders will vote on electing seven directors (Matthew Conlin, Donald Mathis, James P. Geygan, Richard C. Pfenniger, Jr., David A. Graff, Ryan Schulke, Barbara Shattuck Kohn), advisory approval of 2025 named executive officer compensation, ratification of Grant Thornton LLP as auditor for 2026, approvals for May and August warrants/pre-funded warrants issued to directors/officers to comply with Nasdaq rules, a charter amendment for officer exculpation, an amendment to increase shares reserved under the 2022 Omnibus Equity Incentive Plan from 3,666,666 to 5,566,666, and an adjournment proposal. The Board recommends voting 'FOR' all proposals, with varying voting thresholds including majority of outstanding shares for the charter amendment.
- ·Record date: April 23, 2026
- ·Annual Meeting access: www.virtualshareholdermeeting.com/FLNT2026 (16-digit control number required for voting stockholders)
- ·Proposal 6 (Charter Amendment) requires majority of outstanding shares; abstentions and broker non-votes count as 'AGAINST'
- ·Proposals 1-5, 7-8 determined by majority of votes cast; abstentions and broker non-votes have no effect
- ·Proposal 3 (Auditor Ratification) is 'routine' allowing broker discretionary votes
06-05-2026
Holley Inc. held its 2026 Annual Meeting of Stockholders on May 1, 2026, where shareholders elected directors James Coady (59.3M votes for, 29.4M withheld) and Ginger Jones (80.2M votes for, 8.5M withheld), ratified Grant Thornton LLP as auditors (102.5M for), approved Say-on-Pay (87.7M for), selected annual frequency for future Say-on-Pay votes (60.8M for annually), and approved the amendment to the 2021 Omnibus Incentive Plan (61.0M for, but 27.6M against). While most proposals received strong support, the Plan amendment and James Coady's election saw notable opposition or withheld votes, indicating some shareholder dissent.
- ·Annual Meeting proposals detailed in proxy statement filed March 20, 2026.
- ·Board will hold Say-on-Pay votes annually until next frequency vote.
- ·Directors elected to serve until 2029 Annual Meeting.
- ·Fiscal year for auditor ratification ends December 31, 2026.
06-05-2026
Louisiana-Pacific Corporation (LP) reported Q1 2026 consolidated net sales of $574 million, down $149 million or approximately 21% YoY from $723 million, with Siding sales decreasing 10% to $360 million due to lower volumes despite higher prices, and OSB sales plunging 37% to $168 million on lower prices and volumes. Adjusted EBITDA fell $80 million to $82 million, and net income dropped $64 million to $27 million ($0.39 per diluted share). Guidance indicates continued challenges with Siding net sales ~4% down in Q2 and ~2% for FY2026, alongside negative OSB Adjusted EBITDA of -$10 million in Q2 and -$40 million for the year.
- ·Siding Q1 price increase of 9% offset by 18% volume decline
- ·OSB Structural Solutions Q1 price down 21%, volume down 18%; Commodity OSB price down 31%, volume down 12%
- ·Other operations net sales down $8 million, Adjusted EBITDA down $9 million in Q1
- ·FY2026 capex guidance ~$390 million ($200 million strategic growth, $190 million sustaining maintenance)
- ·Conference call held May 6, 2026 at 11 a.m. ET
06-05-2026
Prime Capital Management Co Ltd, based in Hong Kong, filed its 13F-HR report on May 6, 2026, for the quarter ended March 31, 2026, disclosing 7 equity holdings all with sole voting and disposition power. The portfolio features significant positions in technology stocks including NVIDIA Corporation ($154200818, 884179 shares), Tesla Inc ($267608327, 719861 shares), and Taiwan Semiconductor Mfg Ltd ($224333914, 663808 shares). Other holdings include Cava Group Inc ($83458867, 1031630 shares), Micron Technology Inc ($85344465, 252618 shares), E L F Beauty Inc ($36640866, 604535 shares), and Kinsale Cap Group Inc ($39461047, 115498 shares).
- ·All holdings reported with sole shared voting power, sole shared disposition power, and no other powers.
- ·Filer CIK: 0001448793
- ·SEC file number: 028-14988
- ·Business address: Unit 2303 Low Block Grand Millennium Plz, 181 Queen's Road Central, Hong Kong
06-05-2026
Barrel Energy Inc. dismissed Fruci & Associates II, PLLC as its independent registered public accounting firm on April 28, 2026, following their audits of fiscal years 2023 and 2024 and review of financials through September 30, 2025. The Company engaged Shah Teelani & Associates Chartered Accountants on April 21, 2026, to audit the fiscal year ended December 31, 2025. No disagreements on accounting principles, financial disclosures, auditing scope, or reportable events occurred with the prior auditor.
- ·Previous auditor provided services for Form 10 filed February 23, 2026.
- ·Letter from Fruci & Associates II, PLLC to be filed by amendment as Exhibit 16.1.
- ·Company address: 3859 S Valley View Blvd, Ste 2 #107, Las Vegas, NV 89103.
06-05-2026
American Financial & Tax Strategies Inc filed its 13F-HR report on May 6, 2026, disclosing total holdings of $205760881 across 97 positions as of March 31, 2026. The portfolio consists entirely of sole discretionary shares in a diversified mix of ETFs and individual stocks, with no other voting authority or options reported. Largest positions include Vanguard Total International Bond ETF (233767 shares, $11232481), Vanguard Russell 1000 Growth ETF (80362 shares, $8814950), and Schwab U.S. Large-Cap Value ETF (109752 shares, $3347436).
- ·All 97 positions held with sole voting power (SH SOLE).
- ·No put/call options or other manager authority reported.
- ·Notable stock holdings: Apple Inc (4150 shares, $1053258), Amazon.com Inc (4517 shares, $940756), Cisco Sys Inc (19140 shares, $1485073).
06-05-2026
On May 5, 2026, Oxford Square Capital Corp. entered into Amendment No. 1 to its Amended and Restated Equity Distribution Agreement originally dated August 16, 2024, with sales agents Oxford Square Management, LLC, Oxford Funds, LLC, Lucid Capital Markets, LLC, and Ladenburg Thalmann & Co. Inc. The amendment enables continued sales of common stock under the company's effective shelf registration statement on Form N-2 (Registration No. 333-290511), as supplemented by a prospectus dated May 5, 2026. Dechert LLP issued a legality opinion with respect to the shares to be sold pursuant to the agreement.
- ·Principal executive offices: 8 Sound Shore Drive, Suite 255, Greenwich, CT 06830; telephone: (203) 983-5275.
- ·Filing date: May 6, 2026; earliest event reported: May 5, 2026.
- ·Exhibits include Amendment No. 1 (Exhibit 1.1), Opinion of Dechert LLP (Exhibit 5.1), and Consent of Dechert LLP (Exhibit 23.1).
06-05-2026
TCFG Investment Advisors, LLC filed a 13F-HR report disclosing its holdings as of March 31, 2026, with a total portfolio value of $267470940 across 274 positions, all held with sole voting power. Top holdings include Apple Inc. COM at $14964597 (58964 shares), NVIDIA Corporation COM at $13224244 (75827 shares), and Amazon.com Inc COM at $5801806 (27857 shares). No changes or performance metrics were detailed in the filing.
- ·Filing date: May 06, 2026
- ·Report period end: March 31, 2026
- ·All 274 positions held as SH SOLE with no other voting or disposition power indicated
06-05-2026
Munro Partners filed its Form 13F-HR on May 6, 2026, disclosing 59 equity positions held as of March 31, 2026, with a total market value of $2,951,026,742. Top holdings include NVIDIA Corporation ($288,414,174 market value, 1,653,751 shares), GE Vernova Inc. ($226,895,516 market value, 259,933 shares), Amazon.com Inc. ($166,386,486 market value, 798,898 shares), and Alphabet Inc. ($125,280,403 market value, 435,667 shares). All reported positions are held with sole voting power.
- ·Report signed by Lechelle Hooper on May 5, 2026
- ·Munro Partners based in Melbourne, Australia
- ·All holdings reported with sole voting power and no other voting authority or shared discretion
06-05-2026
Next Bridge Hydrocarbons, Inc. filed an S-1/A registration statement on May 6, 2026, for its IPO, disclosing oil and gas leasehold interests totaling 2,838 gross acres (2,229 net) across Texas Hazel Project, Oklahoma Viking properties, and Louisiana Wildcat projects as of December 31, 2025. Investments in properties rose sharply to $4,803,655 in 2025 from $1,692,885 in 2024, driven by $4,803,655 in development costs. However, production revenue fell 17.8% YoY to $10,343, with oil volumes down 14% to 86 Bbls and gas down 30% to 2,441 Mcf from Oklahoma properties, no revenue from Hazel, one dry hole drilled, no proved reserves, and full $5,373,207 impairment of unevaluated costs.
- ·No proved reserves (0 Bbls oil, 0 Mcf gas, 0 BOE) as of Dec 31, 2025 and 2024.
- ·Company has no employees and relies on independent consultants and contractors.
- ·Average production cost $20.12 per BOE in 2025 vs $272.34 in 2024 (significant decline).
- ·No production revenue from Hazel Project in 2025 or 2024 due to option agreement terms.
- ·Hazel Project: 806 gross acres (645 net), all developed.
- ·Oklahoma Viking: 640 gross acres (192 net), all developed.
- ·Louisiana Wildcat: 1,392 gross/net acres, all undeveloped.
06-05-2026
TopTier Wealth Management, LLC filed its 13F-HR report on May 6, 2026, disclosing 795 equity positions valued at $162660122 as of March 31, 2026, all held with sole voting and dispositive power. Largest holdings include Invesco QQQ Trust at $10480313 (18158 shares), WisdomTree US SmallCap Fund at $5498932 (94730 shares), and State Street SPDR S&P 500 ETF at $4756097 (7313 shares). No changes or performance metrics relative to prior periods are reported in this snapshot filing.
- ·Report filed as of May 6, 2026, for period ending March 31, 2026.
- ·No other investment managers included (0 reported).
- ·All positions listed as SH SOLE with 0 shared, 0 other voting power.
06-05-2026
Skyworks Solutions, Inc. updated on its proposed merger with Qorvo, Inc. during its Q2 FY2026 earnings call on May 5, 2026, stating regulatory reviews are progressing as expected with entry into Phase II of the China SAMR review and increasing hope for a late 2026 close ahead of formal early 2027 guidance. The company expressed strong confidence in achieving at least $500 million in anticipated synergies and supported Qorvo's $400 million share repurchase per merger agreement covenants. No delays or setbacks were highlighted, with integration planning advancing well.
- ·Entered Phase II of China SAMR regulatory review
- ·Registration Statement on Form S-4 (File No. 333-291947) declared effective December 23, 2025
- ·Formal merger closing guidance: early calendar 2027
06-05-2026
Intentional Wealth Strategies, LLC filed its 13F-HR on May 06, 2026, reporting holdings across 942 securities as of March 31, 2026, with all positions held on a sole discretionary basis. Top positions include Invesco QQQ Trust ($2621552 market value, 4542 shares), Vanguard Extended Market ETF ($2294948, 11151 shares), and iShares Gold Trust ($2022655, 22943 shares), alongside stocks like Amazon.com Inc ($329900, 1584 shares) and Johnson & Johnson ($406259, 1662 shares). No prior period data or changes are disclosed in the filing.
- ·Filer CIK: 0002119881
- ·State of incorporation: CO
- ·Business address: 1125 Kelly Johnson Blvd, Suite 111, Colorado Springs, CO 80920
- ·All holdings designated as SOLE (sole voting and investment discretion)
- ·SEC file number: 028-26853
06-05-2026
Wall Street Financial Group, Inc. filed its 13F-HR on May 6, 2026, disclosing 667 equity holdings as of March 31, 2026, with a total market value of $168.87 billion, all managed with sole investment and voting discretion. Largest positions include NVIDIA Corporation at $7.38 billion (42,334 shares), Apple Inc. at $5.22 billion (20,567 shares), Palantir Technologies Inc. at $1.90 billion (13,022 shares), Eli Lilly & Co. at $2.00 billion (2,176 shares), and Tesla Inc. at $1.68 billion (4,532 shares). No shared discretion, performance changes, or other voting powers were reported.
- ·All 667 positions held with sole investment discretion and sole voting power (no shared power reported)
- ·Filing covers period ending 03/31/2026
06-05-2026
Shengqi Capital (Hong Kong) Ltd filed its quarterly 13F-HR on May 6, 2026, disclosing equity holdings as of March 31, 2026, with a total portfolio value of approximately $40.9 million. The largest position is 100 shares of Alphabet Inc Class C stock valued at $28.686 million, followed by 200 shares of ProShares UltraPro QQQ valued at $8.336 million, 100 shares of iShares Bitcoin Trust ETF valued at $3.842 million, and 100 shares of Greenland Mines Ltd valued at $0.033 million. No prior period comparisons are provided in the filing.
- ·Filing signed by Lau Ka Chun on April 14, 2026
- ·All holdings reported as sole voting power with no shared voting, puts/calls, or other managers
- ·Company address: Room 1805, 90 Connaught Rd Central, Sheung Wan, Hong Kong
06-05-2026
My Portfolio Guide, LLC reported 166 equity holdings totaling $180,815,716 as of March 31, 2026, in its quarterly 13F-HR filing. The portfolio features heavy allocations to SPDR ETFs (e.g., $29.4M, $16.3M positions), gold/miners trusts ($18.8M), First Trust funds ($11.5M), and individual stocks like Apple Inc ($7.1M). All positions are held with sole voting and sole dispositive power; no prior period comparisons are available.
- ·Filing date: May 6, 2026
- ·Report period end: March 31, 2026
- ·Business address: 3020 Old Ranch Parkway, Suite 300, Seal Beach, CA 90740
- ·All holdings with sole voting power (SH SOLE) and no shared power indicated
06-05-2026
Standex International Corp reported robust Q3 FY2026 results with net sales increasing 8% YoY to $224,595 thousand, gross profit up 12% to $91,932 thousand, and net income attributable to common stockholders surging to $66,978 thousand from $21,880 thousand, driven by a $56,837 thousand gain on sale of business; nine-month sales rose 17% YoY to $663,346 thousand with net income to $84,155 thousand. However, total assets declined 3% to $1,526,777 thousand from $1,566,880 thousand at June 30, 2025, goodwill fell 4% to $585,503 thousand, inventories remained flat at $129,563 thousand, and other comprehensive loss included $39,427 thousand in foreign currency translation losses for the nine months.
- ·Diluted EPS total for three months ended March 31, 2026: $5.55 (up from $1.81 YoY)
- ·Diluted EPS total for nine months ended March 31, 2026: $6.98 (up from $3.41 YoY)
- ·Restructuring costs three months: $2,989 thousand (up from $1,976 thousand YoY)
- ·Weighted average diluted shares three months March 31, 2026: 12,062 thousand
- ·Dividends declared nine months: $1.00 per share ($12,030 thousand total)
06-05-2026
Thomas Story & Son LLC, an institutional investment manager, disclosed total holdings of $260532955 across 51 positions in its 13F-HR filing as of March 31, 2026. Top holdings include Costco Wholesale Corporation at $17232510 (17294 shares), Johnson & Johnson at $15299622 (62591 shares), Williams Sonoma Inc at $14082622 (77237 shares), Visa Inc at $14629172 (48403 shares), and Tractor Supply Co at $11924183 (263227 shares). Other significant positions include Apple Inc ($12033897), Alphabet Inc Cl A ($10992269), and Chevron Corporation ($10869492).
- ·Filing submitted on May 06, 2026, covering period ending March 31, 2026.
- ·All positions reported as sole discretionary holdings (SH SOLE).
- ·Minor share adjustments observed in several positions (e.g., Johnson & Johnson: 62591 shares vs. prior reported 62590).
06-05-2026
On May 5, 2026, Patriot National Bancorp, Inc. posted a presentation on its Investor Relations website containing certain Q1 2026 financial information for its wholly owned subsidiary, Patriot Bank, National Association. The presentation is furnished as Exhibit 99.1 under Items 7.01 and 9.01 of this Form 8-K. This disclosure is made pursuant to Regulation FD and is not deemed 'filed' for purposes of the Exchange Act.
- ·Investor Relations website: https://bankpatriot.com/Learn/About/Investor-Relations
- ·Filing pertains to Q1 2026 financial information
06-05-2026
Life Time Group Holdings, Inc. agreed to repurchase 2,192,500 shares of its common stock at $28.60 per share for an aggregate $62,705,500 from existing stockholders, including affiliates of Leonard Green & Partners, L.P., TPG Inc., and Partners Group (USA) Inc. These selling stockholders are concurrently selling 8,770,000 shares at the same price for $250,822,000 to an affiliate of Atairos Group, Inc., for a total of 10,962,500 shares sold. Following the transactions, the selling funds will hold approximately 8.5%, 6.1%, and 1.3% of the Company's common stock based on 222,602,738 shares outstanding as of May 1, 2026.
- ·Investor Purchase expected to settle in two tranches, with second tranche after HSR Act waiting period expires or terminates.
- ·Share Repurchase funded with cash on hand.
- ·Selling Stockholders include affiliates of Leonard Green & Partners, L.P., TPG Inc., and Partners Group (USA) Inc.
06-05-2026
AtriCure reported Q1 2026 worldwide revenue of $141.2 million, up 14.3% YoY, with U.S. revenue accelerating to 14.9% growth to $116.2 million driven by pain management (+29.5%), open ablation (+17.3%), and appendage management (+15.0%), while achieving profitability with net income of $0.1 million and adjusted EBITDA of $17.1 million (+95% YoY). However, U.S. minimally invasive ablation revenue declined 24.7% YoY to $6.4 million, and international revenue growth slowed to 11.5% (3.3% constant currency). Full-year 2026 guidance includes revenue of $600-610 million and adjusted EBITDA of $80-82 million.
- ·Gross margin expanded 246 basis points to 77.4% due to favorable product and geographic mix.
- ·Cash and cash equivalents decreased to $146.2 million from $167.4 million at year-end 2025.
- ·FY2026 adjusted EPS guidance $0.09-$0.15; net EPS $0.00-$0.04.
- ·Conference call held May 5, 2026, replay available for 90 days.
06-05-2026
United States Antimony Corporation (UAMY) filed a Form 8-K on May 6, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), furnishing Exhibit 99.1 consisting of a press release dated May 5, 2026. The filing contains no specific financial, operational, or performance details. It was signed by Gary C. Evans, Chairman and Chief Executive Officer.
06-05-2026
VSM Wealth Advisory, LLC filed its 13F-HR on May 6, 2026, reporting 505 equity positions with a total market value of $334,834,908 as of March 31, 2026, all held with sole voting power. Notable holdings include Dimensional US Core Market ETF ($10,022,624), Dimensional U.S. Market ETF ($8,747,556), and Dimensional U.S. Core Equity 2 ETF ($8,543,092), alongside individual stocks like Apple Inc. ($2,826,656). The portfolio shows no reported changes in ownership structure or performance metrics.
- ·Filing period end date: March 31, 2026
- ·Date as of change: May 5, 2026
- ·All positions reported as SH SOLE (sole voting power), with no shared power, none or other
06-05-2026
VISTA CAPITAL PARTNERS, INC. filed its 13F-HR on May 06, 2026, disclosing holdings in 156 securities totaling $994149469 as of March 31, 2026. The portfolio features heavy ETF allocations, led by Vanguard Total U.S. Stock Market Index Fund at $358654303, Vanguard Value Index Fund at $149722873, and Vanguard REIT Index Fund at $128473633. Notable individual stock positions include Microsoft Corp ($12023179), Apple Inc ($12845347), and Nvidia Corp ($6043165), with no comparative prior period data provided.
- ·All positions reported with sole voting power
- ·Adviser CIK: 0001486946
- ·SEC file number: 028-14437
- ·Adviser ID: 801-60536
06-05-2026
Breeze Acquisition Corp. II, a blank check company, filed Amendment No. 4 to its Form S-1 registration statement on May 5, 2026, in preparation for an IPO of up to 12,500,000 units (assuming no exercise of underwriters' over-allotment option), each comprising one ordinary share and one Share Right. Post-offering and private placement (447,500 private placement units at $10.00 per unit for $4,475,000), 12,947,500 units, 17,689,392 ordinary shares, and 2,589,500 Share Rights will be outstanding. The sponsor acquired 5,050,676 founder shares for $25,000, subject to transfer restrictions until six months post-initial business combination or certain price triggers.
- ·Each Share Right entitles holder to one-fifth (1/5) of one ordinary share upon initial business combination (must hold multiples of five; no fractional shares).
- ·Separate trading of ordinary shares and Share Rights prohibited until post-IPO Form 8-K filed with audited balance sheet.
- ·Founder shares represent 26% of outstanding shares post-offering (excluding private and representative shares) based on maximum offering size expectation of 14,375,000 units.
- ·Initial shareholders agreed to vote founder shares, private placement shares, and certain public shares in favor of initial business combination; waive redemption and liquidating distribution rights on founder/private shares.
06-05-2026
HighMark Wealth Management LLC filed Form 13F-HR on May 6, 2026, reporting its U.S. equity holdings as of March 31, 2026, with no additions, reductions, or other changes indicated across all positions. The portfolio is heavily weighted toward healthcare stocks, including top holdings Axogen Inc (value 11427862), Centessa Pharmaceuticals PLC (9405100), and Anaptysbio Inc (5216013). Other significant positions include Apple Inc (1989756), Eli Lilly & Co (1589362), and a diversified mix of technology, ETFs, and other sectors.
- ·Report period end: 2026-03-31
- ·Filing date: 2026-05-06
- ·All positions reported as SH SOLE with zero values in change columns (no buys, sells, or other adjustments)
- ·Adviser CRD number: 164790
- ·Filer CIK: 0001802451
- ·Business address: 944 Inwood Avenue N., St. Paul, MN 55128
06-05-2026
Quantum Leap Acquisition Corp, a blank check company targeting AI, quantum computing, and blockchain sectors, announced the pricing of its $200 million initial public offering of 20,000,000 units at $10.00 per unit, with trading expected to begin on NYSE under 'QLEPU' on May 1, 2026, and closing on May 4, 2026. Underwriters A.G.P./Alliance Global Partners received a 45-day option to purchase up to 3,000,000 additional units. The IPO includes one Class A ordinary share and one redeemable warrant per unit, exercisable at $11.50 per share.
- ·Units expected to separate trade with ordinary shares under 'QLEP' and warrants under 'QLEPW'.
- ·Excludes pursuit of targets in China, Hong Kong, Taiwan, and Macau.
- ·Registration statement File No. 333-293359 declared effective April 30, 2026.
- ·Leadership team has more than six decades of collective experience in relevant sectors.
06-05-2026
Plutonian Acquisition Corp II consummated its initial public offering (IPO) on April 29, 2026, selling 10,000,000 units at $10.00 per unit for gross proceeds of $100,000,000. Simultaneously, the company completed a private placement of 210,000 units to Plutonian Capital II LLC at $10.00 per unit, generating $2,100,000 in proceeds. An audited balance sheet reflecting these transactions is included as Exhibit 99.1.
- ·Each unit consists of one Class A ordinary share ($0.0001 par value) and one right entitling holder to 1/4 Class A ordinary share upon initial business combination.
- ·Securities traded on NYSE: PLUNU (units), PLUN (Class A shares), PLUNR (rights).
- ·Event date: April 29, 2026; Filing date: May 6, 2026.
06-05-2026
Shepherd Wealth Management Ltd Liability Co filed a 13F-HR report disclosing total holdings valued at $133,511,272 across 52 positions as of March 31, 2026. Top holdings include iShares 1-3 Year Treasury Bond ETF ($27,527,415), State Street SPDR S&P 500 ETF Trust ($21,337,673), and iShares 20+ Year Treasury Bond ETF ($18,443,459). Other significant positions feature NVIDIA Corporation ($4,554,587), Invesco QQQ Trust ($11,222,314), and Health Care Select Sector SPDR Fund ($9,941,859).
- ·Filing submitted on May 6, 2026, for period ending March 31, 2026
- ·All positions reported as sole discretionary with no voting or other authority changes indicated
- ·Additional notable holdings: Tesla Inc ($2,823,588), Palantir Technologies Inc ($2,923,563), Apple Inc ($1,388,092)
06-05-2026
Bread Financial Holdings, Inc. announced the pricing of an underwritten public offering of 4,800,000 depositary shares, each representing a 1/40th interest in a share of its 8.875% Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B, with a liquidation preference of $25 per depositary share. The underwriters, led by Morgan Stanley & Co., LLC and others, were granted an option to purchase up to an additional 720,000 depositary shares within 30 days. Net proceeds will be used for general corporate purposes, potentially including contributions to subsidiary Comenity Capital Bank and share repurchases.
- ·Offering registered under Securities Act on Form S-3 (Registration No. 333-291573).
- ·Prospectus supplement dated May 5, 2026, to be filed pursuant to Rule 424(b).
- ·Underwriting agreement dated May 5, 2026.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
More from: US Pre-Market SEC Filings Roundup
🇺🇸 More from United States
View all →April 28, 2026
US Merger & Acquisition SEC Filings — April 28, 2026
US Merger & Acquisition SEC Filings
April 28, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings — April 28, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings
April 28, 2026
US Executive Officer Management Changes SEC — April 28, 2026
US Executive Officer Management Changes SEC
April 28, 2026
US Corporate Distress Financial Stress SEC Filings — April 28, 2026
US Corporate Distress Financial Stress SEC Filings